Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $239,400 | 14 | 66.7% |
| Honoraria | $114,000 | 1 | 31.8% |
| Unspecified | $5,360 | 4 | 1.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $358,760 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $119,360 | 5 | PFIZER INC. ($119,360) |
| 2022 | $158,175 | 4 | PFIZER INC. ($158,175) |
| 2021 | $81,225 | 10 | PFIZER INC. ($81,225) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2023 | PFIZER INC. | PAXLOVID (Drug) | — | In-kind items and services | $780.00 | Research |
| Study: NIRMATRELVIR CLINICAL PUBLICATION PROGRAM • Category: INFECTIOUS DISEASES | ||||||
| 06/16/2023 | PFIZER INC. | PAXLOVID | — | In-kind items and services | $780.00 | Research |
| Study: PF07304814 PF07817883 NIRMATRELVIR MULTI PRODUCT CLINICAL PUBLICATION PROGRAM | ||||||
| 06/09/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $114,000.00 | General |
| 05/05/2023 | PFIZER INC. | PAXLOVID | — | In-kind items and services | $1,900.00 | Research |
| Study: PF07304814 PF07817883 NIRMATRELVIR MULTI PRODUCT CLINICAL PUBLICATION PROGRAM | ||||||
| 01/02/2023 | PFIZER INC. | PAXLOVID (Drug) | — | In-kind items and services | $1,900.00 | Research |
| Study: PAXLOVID CLINICAL PUBLICATION PROGRAM • Category: INFECTIOUS DISEASES | ||||||
| 11/28/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,376.90 | General |
| 11/28/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,898.10 | General |
| 04/25/2022 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $114,000.00 | General |
| 01/10/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $39,900.00 | General |
| 12/20/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $5,700.00 | General |
| 11/22/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $3,325.00 | General |
| 11/15/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
| 11/08/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $3,800.00 | General |
| 11/01/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $9,025.00 | General |
| 08/30/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $11,875.00 | General |
| 08/02/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $9,975.00 | General |
| 07/05/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $8,550.00 | General |
| 06/14/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $13,775.00 | General |
| 06/14/2021 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $7,600.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PF07304814 PF07817883 NIRMATRELVIR MULTI PRODUCT CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $2,680 | 2 |
| PAXLOVID CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,900 | 1 |
| NIRMATRELVIR CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $780.00 | 1 |
About Dr. Mark Cullen, MD
Dr. Mark Cullen, MD is a Occupational Medicine healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215919956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Cullen, MD has received a total of $358,760 in payments from pharmaceutical and medical device companies, with $119,360 received in 2023. These payments were reported across 19 transactions from 1 company. The most common payment nature is "Consulting Fee" ($239,400).
Practice Information
- Specialty Occupational Medicine
- Location Stanford, CA
- Active Since 11/17/2005
- Last Updated 05/14/2009
- Taxonomy Code 2083X0100X
- Entity Type Individual
- NPI Number 1215919956
Products in Payments
- PAXLOVID (Drug) $2,680
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.